Skip to content

Cognitive Remediation in Forensic Mental Health Care

Cognitive Remediation in Forensic Mental Health Care

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04610697
Acronym
CRFMHC
Enrollment
30
Registered
2020-10-30
Start date
2020-02-10
Completion date
2026-02-10
Last updated
2025-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD, Aggression, Antisocial, Anxiety, Cognitive Dysfunction, Depression, Offenders, Psychotic Disorders, Schizophrenia, Substance Use Disorders, TBI (Traumatic Brain Injury), Violence

Keywords

Cognitive Remediation, Cognitive Training, Cognitive Enhancement, Cognitive Rehabilitation, Neuropsychological Rehabilitation, Executive Function, Forensic Mental Health, Forensic Psychology, Forensic Neuropsychology, Forensic Neuroscience, Forensic Rehabilitation, Cognition, Executive Functioning

Brief summary

Forensic patients often display cognitive deficits, particularly in the domain of executive functions, that represent a challenge to forensic rehabilitation. One empirically-validated method to train executive functions is cognitive remediation, which consists of cognitive exercises combined with coaching. This trial investigates whether cognitive remediation can improve cognitive, functional, and clinical outcomes in forensic inpatients.

Detailed description

Forensic patients often display deficits in executive functions, namely difficulties in planning, strategic thinking, problem-solving, and inhibiting inappropriate behavior. Such deficits are transdiagnostic and often underlie behavioral incidents, undermine reintegration into the community, and increase recidivism risk. Despite this, forensic programs usually do not include executive function training. One approach to train executive functions is cognitive remediation, which consists of behavioral exercises engaging cognitive skills, supported by coaching. In various mental health conditions, cognitive remediation has been repeatedly associated with improvements in cognitive, functional, and clinical outcomes, with small-to-moderate effect sizes. Thus, it should be clarified whether this approach can lead to similar improvements in forensic populations. In the present trial, we will investigate whether 12 hours over 6 weeks of computerised cognitive remediation administered using tele-health can improve executive functions relative to an active control condition in a sample of 30 forensic inpatients (Aim 1). We will further examine the effect of cognitive remediation (vs. active control) on other variables that are critical for forensic rehabilitation, namely oppositional behaviour, functional capacity, and mental health symptoms (Aim 2). Lastly, we will explore whether any effects persist 12 weeks following cognitive remediation (Aim 3). Cognitive remediation is an evidence-based inexpensive training method that could be integrated into forensic healthcare practice. In the long term, the expected cognitive, functional, and clinical improvements associated with cognitive remediation have the potential to result in shorter hospitalisations and reduced recidivism rates.

Interventions

BEHAVIORALCognitive Remediation

Cognitive Remediation consists of exercises, preferably supported by coaching, aimed at engaging cognitive skills and, as a result, at improving cognition as well as functional and clinical outcomes.

BEHAVIORALActive Control

Active control condition for cognitive remediation, matched in terms of session modality, number, duration, frequency, and format.

Sponsors

The Royal Ottawa Mental Health Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Participants and personnel conducting the assessments will be unaware of group assignment. At the halfway mark of recruitment, we will perform preliminary analyses including intention-to-treat liner mixed models. Study staff performing the assessment visits and participants will remain blinded to the study conditions.

Intervention model description

Double blind randomised controlled trial with active control condition. Given the clinically heterogeneous recruitment pool, pseudo-randomization will be employed to match groups on the main diagnosis.

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

i1. Age 18 - 55; i2. Ability to read and speak in fluent English; i3. Current status as inpatient on the Forensic Treatment Unit.

Exclusion criteria

e1. Intellectual disability; e2. TBI with loss of consciousness followed by known severe neurological sequelae requiring hospitalisation and rehabilitation.

Design outcomes

Primary

MeasureTime frameDescription
Executive Functionwithin 1 week prior and 1 week after training, as well as at a 12-week follow-up.We will measure executive functions using tests from the Cambridge Neuropsychological Test Automated Battery (CANTAB; Sandberg, 2011).

Secondary

MeasureTime frameDescription
Oppositional Behaviorwithin 12 weeks before and 12 weeks after training.We will measure oppositional behavior using case-manager reports over the 12 weeks preceding and following the study. We will code frequency and severity of behavioral incidents (e.g., verbal and physical aggression) and compliance with rehabilitative interventions.
Functional Capacitywithin 1 week prior and 1 week after training, as well as at a 12-week follow-up.We will measure perceived functioning in daily life using the Generalized Self-Efficacy Scale (GSES; Schwarzer & Jerusalem, 1995), scored on a scale of 10 to 40, with higher values indicating higher perceived general self-efficacy.
Mental Health Symptomswithin 1 week before and 1 week after training, as well as at a 12-week follow-up.We will measure mental health symptoms using the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM; Evans et al., 2000), scored on a scale of 0 to 136, with greater scores indicating greater psychological distress.

Countries

Canada

Contacts

Primary ContactPatrizia Pezzoli, PhD
p.pezzoli@ucl.ac.uk613-722-6521

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026